logo
ProjectActive

Neolpharma

Sector: Manufacturing (Industrial) • Location: Mexico

Source: IFC Project Disclosures

Founded more than 31 years ago, Grupo Neolpharma (the “Company”) is a Mexico-based, family-owned, pharmaceutical company focused on the development, manufacture, distribution and sale of branded and unbranded generic medicines.  Through its related companies, Neolpharma has presence in Mexico, Puerto Rico, Peru and Ecuador.  It exports from Mexico to Colombia, El Salvador, Panama, Costa

Status
Prospective
Sector
Manufacturing (Industrial)
Location
Mexico
Updated
19 Nov 2026
Source
IFC Project Disclosures

ConstructChat

Ask ConstructChat about Neolpharma

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Neolpharma” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Mexico. Taiyo aggregates data on it from IFC Project Disclosures.

Participants

Not available for this record.

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Founded more than 31 years ago, Grupo Neolpharma (the “Company”) is a Mexico-based, family-owned, pharmaceutical company focused on the development, manufacture, distribution and sale of branded and unbranded generic medicines.  Through its related companies, Neolpharma has presence in Mexico, Puerto Rico, Peru and Ecuador.  It exports from Mexico to Colombia, El Salvador, Panama, Costa Rica, Guatemala, Honduras and the Dominican Republic.Neolpharma owns an active pharmaceutical ingredients (“API”) production plant, four pharmaceutical finished formulations production plants; one USFDA/EMA approved plant in Puerto Rico; two distribution companies; and a pharmacy chain in Mexico with 47 branches.  It is one of the leading domestic pharmaceutical companies in Mexico, primarily focused on prescription generics, with a portfolio of over 250 products in therapeutic areas such as central nervous system, cardiovascular, oncology and diabetes.  As of today, it employs approximately 2,485 full-time employees of which 49% are women.The proposed IFC’s financing aims to support Grupo Neolpharma’s expansion plan in Mexico, which includes ramping up production capabilities and climate related projects (the “Project”).                                                  

Original sector

other

Location

Country

Mexico

Source

Source

IFC Project Disclosures

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2026-09-09

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project